Healthcare -
Biotechnology - NASDAQ - US
$ 11.7775
-1.36 %
$ 443 M
Market Cap
7.01
P/E
Price Target
Average
61.32%
Revenue Forecast
Estimate
33.18%
EBIT
Estimate
328.42%
Net Income
Estimate
--186.43%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Entrada Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for TRDA of $19 , with forecasts ranging from
a
low of
$18 to a high of $20 .
TRDA Lowest Price Target
Wall Street Target
18 USD
52.83%
TRDA Average Price Target
Wall Street Target
19 USD
61.32%
TRDA Highest Price Target
Wall Street Target
20 USD
69.82%
REVENUE FORECAST
Revenue Forecast Chart TRDA
EBIT FORECAST
EBIT Forecast Chart TRDA
NET INCOME FORECAST
Net Income Chart TRDA